Dr. Matthew Trese, DO
- Medicare services, 2024
- 16,268
- Medicare patients, 2024
- 605
- Part D claims, 2024
- 302
- MIPS score, 2024
- 95
- Hospital affiliations
- 1
- Practice address
- 3555 W 13 Mile Rd, Royal Oak, MI 48073
- Practice phone
- Call (248) 551-2250
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Beaumont Neuroscience Center - Royal Oak
Royal Oak, Michigan
Find Dr. Trese's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew Trese is a retina specialist (ophthalmology) physician in Royal Oak, Michigan
Dr. Trese practices at Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan.
Dr. Trese's NPI, 1174973416, was assigned on June 17, 2016. Dr. Trese graduated from Michigan State University College of Osteopathic Medicine in 2016. Dr. Trese holds Michigan license 5101025415.
- NPI
- 1174973416NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8123312949
- NPI enumeration date
- June 17, 2016
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (248) 551-2250
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 36
- Medical school graduation
- 2016
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Matthew Trese practices at Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan
Dr. Trese's primary practice is Beaumont Neuroscience Center - Royal Oak, at 3555 W 13 Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 551-2250.
- Beaumont Neuroscience Center - Royal Oak3555 W 13 Mile Rd, Royal Oak, MI 48073 · Oakland CountyPhone(248) 551-2250
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Matthew Trese is affiliated with 4 sites of care and 2 medical groups
Dr. Trese's primary practice is Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan. Dr. Trese is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Trese to 2 more group practices and clinics and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Matthew Trese's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trese practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Beaumont Neuroscience Center - Royal Oak | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew Trese is one of 47 retina specialist (ophthalmology) physicians in Michigan
Retina specialist is Dr. Trese's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Trese is licensed in Michigan.
Specialties and state licenses
- Retina specialist (ophthalmology), MichiganPrimary
Retina specialist (ophthalmology) physicians near Dr. Trese
Counts of retina specialist (ophthalmology) physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew Trese billed Medicare for 16,268 services in 2024
CMS data shows 16,268 Medicare services from Dr. Trese across 19 procedure codes in 2024, for 605 Medicare patients. Medicare paid $1,361,697 for them. Every service was in an office.
Dr. Trese's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 6,3292024: 12,663100%
- Tests and treatments
- 2023: 1,6102024: 1,608No change
- Office and hospital visits
- 2023: 1,0532024: 1,22516%
- Surgery
- 2023: 6482024: 75216%
- Imaging
- 2023: 212024: 205%
Dr. Trese compared with the Michigan median for retina specialist (ophthalmology) physicians, 2024
- Dr. Trese
- Michigan median
- Medicare services
- 16,268vs 13,00725% above
- Medicare patients
- 605vs 622Close to median
- Part D claims
- 259vs 30816% below
Medians across 48 retina specialist (ophthalmology) physicians in Michigan with Dmand AI profiles that report each measure.
Dr. Trese's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Trese?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Trese and other retina specialist (ophthalmology) physicians in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Matthew Trese treated 605 Medicare patients in 2024, average age 77
CMS counts 605 Medicare patients who saw Dr. Trese in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Trese's median patient age at 72, with 57% women.
Dr. Trese's Medicare patients by age, 2024
Dr. Trese's Medicare patients by sex, 2024
- Women36761%
- Men23839%
Chronic conditions among Dr. Trese's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis46%
- Diabetes40%
- Chronic kidney disease33%
- Ischemic heart disease33%
- Atrial fibrillation22%
- Mood disorders21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Trese's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women57%
- Men43%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Matthew Trese wrote 302 Medicare Part D claims in 2024
In 2024, Dr. Trese wrote 302 Medicare Part D claims for 110 patients. 64% of them were for generic drugs. CMS names the drug for 259 of them, across 7 drugs with 11 or more claims each, at $9,532 in total drug cost. In 2023, CMS named 213 claims across 7 drugs.
Dr. Trese's Part D claims by kind of drug, 2024
- Generic192 claims64%
- Brand-name110 claims36%
Dr. Trese's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2132024: 25922%
Drugs named by CMS: 7 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Matthew Trese scored 95 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Trese for performance year 2024, reported as part of a group. Dr. Trese accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Trese's MIPS scores, performance year 2024
- 95of 100Final score
- 91.4of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew Trese received $4,823 in industry payments from 2016 to 2025
CMS Open Payments shows 79 general payments to Dr. Trese from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alimera Sciences, Inc. paid the most, $1,373.
General payments to Dr. Trese by program year, 2016 to 2025
General payments to Dr. Trese by kind, 2016 to 2025
- Food and beverage$4,72598%
- Education$982%
Companies that paid Dr. Trese the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Matthew Trese graduated from Michigan State University College of Osteopathic Medicine
Dr. Trese graduated from Michigan State University College of Osteopathic Medicine in 2016.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Matthew Trese's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew Trese
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew Trese's NPI number?
Dr. Matthew Trese's NPI number is 1174973416. It was assigned on June 17, 2016, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew Trese?
Dr. Matthew Trese is a retina specialist (ophthalmology) physician in Royal Oak, Michigan. The primary specialty in the NPI Registry is Retina Specialist (Ophthalmology) Physician (taxonomy code 207WX0107X).
Where does Dr. Matthew Trese practice?
Dr. Trese practices at 3555 W 13 Mile Rd, Royal Oak, MI 48073. Dr. Trese's primary practice is Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan. Dmand AI also links Dr. Trese to 2 group practices and clinics and 1 medical group.
What is Dr. Matthew Trese's office phone number?
The practice phone on file for Dr. Trese is (248) 551-2250.
What is Dr. Matthew Trese's medical license number?
Dr. Trese holds Michigan license 5101025415.
Which hospitals is Dr. Matthew Trese affiliated with?
Dr. Trese is affiliated with Corewell Health William Beaumont University Hospital.
What medical group is Dr. Matthew Trese part of?
Dr. Trese is linked to Beaumont Medical Group - Specialty Services. Dmand AI links Dr. Trese to 1 more medical group.
Does Dr. Matthew Trese accept Medicare?
Yes. CMS data shows Dr. Trese billed Medicare for 16,268 services in 2024, and Dr. Trese accepts Medicare assignment.
What is Dr. Matthew Trese's MIPS score?
Dr. Trese's MIPS final score for performance year 2024 is 95 out of 100, reported as part of a group.
How many Medicare patients does Dr. Matthew Trese see?
CMS counts 605 Medicare patients who saw Dr. Trese in 2024, with an average age of 77.
Show 5 more questionsShow fewer questions
What services does Dr. Matthew Trese bill to Medicare?
In 2024, Dr. Trese's most billed Medicare services were injected or infused drug (J2777), office visit, established patient (99214) and injected or infused drug (J0178).
Where did Dr. Matthew Trese go to medical school?
Dr. Trese graduated from Michigan State University College of Osteopathic Medicine in 2016.
What drugs does Dr. Matthew Trese prescribe most?
In 2024 Medicare Part D data, Dr. Trese's most prescribed drugs by claims were Prednisolone Acetate, Ketorolac Tromethamine and Brimonidine Tartrate.
Has Dr. Matthew Trese received payments from drug or device companies?
CMS Open Payments shows $4,823 in general payments to Dr. Trese from 21 companies from 2016 to 2025. The largest total came from Alimera Sciences, Inc.
How long has Dr. Matthew Trese been practicing?
Dr. Trese graduated from medical school in 2016, 10 years ago.
Selling to retina specialist practices?
See retina specialist (ophthalmology) physicians in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card